A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the "Back of the Line" as a therapy for dyslipidemia?
作者信息
Toth Peter P, Maki Kevin C
机构信息
Sterling Rock Falls Clinic, 101 East Miller Road, Sterling, IL 61081, USA.
出版信息
J Clin Lipidol. 2008 Oct;2(5):313-7. doi: 10.1016/j.jacl.2008.06.011. Epub 2008 Jun 26.
PMID:21291755
Abstract
摘要
Zotero 插件